Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Imunon, Inc.IMNN · Entity 8041 | Director | July 31, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Imunon, Inc.
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,499 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Grant · Acquired 6,180 · Balance 15,499 F1: Stock granted in lieu of cash for portion of board fees |
Filing footnotes · ownership attribution and instrument terms
F1: Stock granted in lieu of cash for portion of board fees
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 4, 2026 20:14 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 6,180 | $1.59 | $9,826.20 |
DisclosureSEC source: 0001437749-26-025663 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,499 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:12 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 5,011 | $2.20 | $11,024.20 |
DisclosureSEC source: 0001437749-26-018548 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,319 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:06 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 5,881 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001437749-26-000607 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,881 Underlying: Common Stock · 5,881 shares Expires 2036-01-02 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:33 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $9.20 | $0.00 |
DisclosureSEC source: 0001437749-25-025098 · rdgdoc.xml · derivative · entry 2 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2035-08-04 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F3 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:33 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantCommon Stock | 2,040 | $9.20 | $18,768.00 |
DisclosureSEC source: 0001437749-25-025098 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,747 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:21 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001437749-25-008267 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2035-03-14 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:57 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantOption to purchase Imunon common stock · Derivative | 9,072 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001437749-24-028885 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,905 Underlying: Imunon, Inc. Common Stock · 6,072 shares Expires 2034-09-06 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F3 · shares: Option granted in lieu of cash for portion of board fees. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| August 20, 2024 Filed Jan 28, 2025 21:18 UTC | Imunon, Inc. IMNN · Entity 8041 | PurchaseCommon Stock | 25,000 | $1.18 | $29,480.00 |
DisclosureSEC source: 0001437749-25-002027 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,597 F1 · shares: The shares were purchased on the open market. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:05 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantOption to purchase Imunon common stock · Derivative | 3,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020252 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,430 Underlying: Imunon, Inc. Common Stock · 3,500 shares Expires 2034-06-12 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:07 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantOption to purchase Imunon common stock · Derivative | 3,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008340 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,930 Underlying: Imunon, Inc. Common Stock · 3,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:42 UTC | Imunon, Inc. IMNN · Entity 8041 | GrantOption to purchase Imunon common stock · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007412 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,430 Underlying: Imunon, Inc. Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:39 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Common Stock · Derivative | 6,250 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015061 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,587 Underlying: Celsion Corporation Common Stock · 6,250 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:04 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 6,250 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005436 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,337 Underlying: Celsion Corporation Common Stock · 6,250 shares Expires 2032-03-04 Read SEC document |
| May 17, 2021 Filed May 20, 2021 18:10 UTC | Imunon, Inc. CLSN · Entity 8041 | PurchaseCelsion Corporation Common Stock | 5,000 | $1.07 | $5,350.00 |
DisclosureSEC source: 0001437749-21-012889 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,357 F1 · shares: The shares were purchased on the open market. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 20:47 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001437749-21-006767 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,357 Underlying: Celsion Corporation Common Stock · 40,000 shares Expires 2031-03-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:00 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001437749-20-013243 · rdgdoc.xml · derivative · entry 3 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:00 UTC | Imunon, Inc. CLSN · Entity 8041 | Disposition to issuerOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-20-013243 · rdgdoc.xml · derivative · entry 2 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F3 · derivative.exercise_price: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). F3 · derivative.underlying_shares: The transaction reported herein reflects a one-time stock option repricing that became effective on June 15, 2020 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the settlement agreement as filed as Exhibit 10.2 on Form 8K dated June 16, 2020, the per share exercise price of the Employee Stock Option (right to buy) has been amended to increase such per share exercise price from $2.22 to $2.58. There have been no other changes to the terms of the Employee Stock Option (right to buy). Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:00 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 4,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001437749-20-013243 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,357 Underlying: Celsion Corporation Common Stock · 4,000 shares Expires 2030-06-15 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:00 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 6,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-20-003783 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,357 Underlying: Celsion Corporation Common Stock · 6,000 shares Expires 2030-02-25 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. Read SEC document |
| October 03, 2019 Filed Oct 7, 2019 20:36 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 14,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001437749-19-019785 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,357 Underlying: Celsion Corporation Common Stock · 14,000 shares Expires 2029-10-03 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 15, 2019 21:39 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 10,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001437749-19-010121 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,357 Underlying: Celsion Corporation Common Stock · 10,000 shares Expires 2029-05-14 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:39 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 12,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001437749-19-003079 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,357 Underlying: Celsion Corporation Common Stock · 12,000 shares Expires 2029-02-19 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document |
| May 15, 2018 Filed May 16, 2018 21:08 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 50,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001437749-18-010154 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,357 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2028-05-15 F1 · derivative.exercise_price: Represents the closing stock price on the option grant date (February 12, 2018) which was subject to the approval of the Celsion Corporation 2018 Stock Incentive Plan at the Annual Meeting of Stockholders held on May 15, 2018. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:41 UTC | Imunon, Inc. CLSN · Entity 8041 | GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 12,500 | $0.00 Strike: $2.69 | $0.00 |
DisclosureSEC source: 0001437749-17-010473 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Celsion Corporation Common Stock · 12,500 shares Expires 2027-05-30 F1 · derivative.exercise_price: Represents the closing price of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.